Christopher Beck
Chief Operating Officer at CONTEXT THERAPEUTICS INC.
Profile
Christopher Beck is a professional with experience in various pharmaceutical companies.
He is currently working as Senior Vice President-Operations at Context Therapeutics, Inc. Prior to this, he worked as Vice President-Program Management at Galera Therapeutics, Aevi Genomic Medicine, and Formular Pharmaceuticals.
He completed his undergraduate degree at Drexel University and earned an MBA from The Pennsylvania State University.
Christopher Beck active positions
| Companies | Position | Start |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Chief Operating Officer | 05/01/2022 |
Former positions of Christopher Beck
| Companies | Position | End |
|---|---|---|
| AEVI GENOMIC MEDICINE, INC. | Corporate Officer/Principal | - |
| Formular Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
| GALERA THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Training of Christopher Beck
| Drexel University | Undergraduate Degree |
| The Pennsylvania State University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| CONTEXT THERAPEUTICS INC. | Health Technology |
| GALERA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Aevi Genomic Medicine, Inc.
 Aevi Genomic Medicine, Inc. Pharmaceuticals: MajorHealth Technology Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engaged in the discovery of treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded by Andrew Leonard Pearlman on January 27, 2000 and is headquartered in Wayne, PA. | Health Technology |
| Formular Pharmaceuticals, Inc. |
- Stock Market
- Insiders
- Christopher Beck
